In vivo emergence of cefiderocol resistance in Pseudomonas aeruginosa following prolonged treatment at San Martino Policlinico Hospital (HSM), Genoa, Italy

Published: 3 December 2024
Abstract Views: 20
PDF: 21
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Not available.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Yahav D, Giske CG, Grāmatniece A, Abodakpi H, Tam VH, Leibovici L. New β-Lactam-β-Lactamase Inhibitor Combinations. Clin Microbiol Rev. 2020 Nov 11;34(1):e00115-20. doi: 10.1128/CMR.00115-20. Erratum in: Clin Microbiol Rev. 2021 Jan 27;34(2):e00021-21. doi: 10.1128/CMR.00021-21. PMID: 33177185; PMCID: PMC7667665. DOI: https://doi.org/10.1128/CMR.00021-21
Karakonstantis S, Rousaki M, Kritsotakis EI. Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance. Antibiotics (Basel). 2022 May 27;11(6):723. doi: 10.3390/antibiotics11060723. PMID: 35740130; PMCID: PMC9220290. DOI: https://doi.org/10.3390/antibiotics11060723
López-Argüello S, Montaner M, Oliver A, Moya B. Molecular Basis of AmpC β-Lactamase Induction by Avibactam in Pseudomonas aeruginosa: PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants. Int J Mol Sci. 2021 Mar 17;22(6):3051. doi: 10.3390/ijms22063051. PMID: 33802668; PMCID: PMC8002452. DOI: https://doi.org/10.3390/ijms22063051
Fang ZL, Zhang LY, Huang YM, Qing Y, Cao KY, Tian GB, Huang X. OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China. Infect Genet Evol. 2014 Jan;21:124-8. doi: 10.1016/j.meegid.2013.10.027. Epub 2013 Nov 8. PMID: 24211415. DOI: https://doi.org/10.1016/j.meegid.2013.10.027
Teo JQ, Lim JC, Tang CY, Lee SJ, Tan SH, Sim JH, Ong RT, Kwa AL. Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa. mSphere. 2021 Jan 27;6(1):e01026-20. doi: 10.1128/mSphere.01026-20. PMID: 33504661; PMCID: PMC7885320 DOI: https://doi.org/10.1128/mSphere.01026-20

How to Cite

Costa, E., Calabrese, L., Marchese, A., & Di Pilato, V. (2024). <i>In vivo</i> emergence of cefiderocol resistance in <i>Pseudomonas aeruginosa</i> following prolonged treatment at San Martino Policlinico Hospital (HSM), Genoa, Italy. Microbiologia Medica, 39(2). https://doi.org/10.4081/mm.2024.13234